Cargando…
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins
PURPOSE: Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, re...
Autores principales: | Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe E., Park, Jong, Salup, Raoul, Williams, Christopher R., Parnes, Howard, Schell, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340117/ https://www.ncbi.nlm.nih.gov/pubmed/28053292 http://dx.doi.org/10.18632/oncotarget.12222 |
Ejemplares similares
-
Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer
por: Kumar, Nagi B., et al.
Publicado: (2017) -
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome
por: Kumar, Nagi B., et al.
Publicado: (2022) -
Green tea extract for prevention of prostate cancer progression in patients on active surveillance
por: Kumar, Nagi B., et al.
Publicado: (2018) -
Osteoprotective Roles of Green Tea Catechins
por: Huang, Hsuan-Ti, et al.
Publicado: (2020) -
Beneficial Properties of Green Tea Catechins
por: Musial, Claudia, et al.
Publicado: (2020)